ALLERGY THERAPEUTICS PLC

Active West Sussex

Manufacture of pharmaceutical preparations

584 employees website.com
Life sciences and medical technology Manufacture of pharmaceutical preparations
A

ALLERGY THERAPEUTICS PLC

Manufacture of pharmaceutical preparations

Founded 1 Jun 2004 Active West Sussex, United Kingdom 584 employees website.com
Life sciences and medical technology Manufacture of pharmaceutical preparations

Previous Company Names

NETSTAMP LIMITED 1 Jun 2004 — 4 Oct 2004
Accounts Submitted 4 Jan 2026 Next due 31 Dec 2026 8 months remaining
Confirmation
Net assets £-28M £32M 2025 year on year
Total assets £68M £3M 2025 year on year
Total Liabilities £96M £35M 2025 year on year
Charges 6
2 outstanding 4 satisfied

Contact & Details

Contact

Registered Address

Dominion Way Worthing West Sussex BN14 8SA

Telephone

0800 000 0000

Website

www.example.com

Full company profile for ALLERGY THERAPEUTICS PLC (05141592), an active life sciences and medical technology company based in West Sussex, United Kingdom. Incorporated 1 Jun 2004. Manufacture of pharmaceutical preparations. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Balance Sheet & P&L (2013–2025)

Cash in Bank

£12.79M

Decreased by £125.00k (-1%)

Net Assets

-£28.19M

Decreased by £31.90M (-860%)

Total Liabilities

£95.74M

Increased by £34.62M (+57%)

Turnover

£56.29M

Decreased by £437.00k (-1%)

Employees

584

Debt Ratio

142%

Increased by 48 (+51%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

19 Allotments 5,683,956,521 Shares £1631.04m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
20 Feb 2026191,089,599£1.91m£0.01
30 Oct 20251,375,000,000£55.00m£0.04
21 Jan 202513£0.077£0.077
21 Jan 202513£0.077£0.077
30 Nov 20232,565,167£3k£0.001

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (8)

Skygem Acquisition Limited
65.0%
Southern Fox Investments Ltd.
27.4%

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased

Southern Fox Investments Ltd

Cayman Islands

Active
Notified 13 Oct 2023
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Skygem International Holdings Ltd

Unknown

Active
Notified 25 Feb 2026
Nature of Control
  • Ownership Of Shares 50 To 75 Percent

Abbott Laboratories

Ceased 9 Nov 2023

Ceased

Sky Gem Acquisition Limited

Ceased 25 Feb 2026

Ceased

Group Structure

Group Structure

ALLERGY THERAPEUTICS PLC Current Company

Charges

Charges

2 outstanding 4 satisfied

Properties

Properties

2 leasehold 2 total
AddressTenurePrice PaidDate Added
The Energy Centre, Dominion Way, Worthing (BN14 8PB) WORTHING
Leasehold-26 Aug 2021
The Secondary Non-Penicillin Unit, Dominion Way, Worthing (BN14 8PB) WORTHING
Leasehold-10 Apr 2018
The Energy Centre, Dominion Way, Worthing (BN14 8PB)
Leasehold
Added 26 Aug 2021
District WORTHING
The Secondary Non-Penicillin Unit, Dominion Way, Worthing (BN14 8PB)
Leasehold
Added 10 Apr 2018
District WORTHING

Documents

Company Filings

DateCategoryDescriptionDocument
20 Mar 2026Persons With Significant ControlCessation of Sky Gem Acquisition Limited as a person with significant control on 25 Feb 2026
20 Mar 2026Persons With Significant ControlSkygem International Holdings Ltd notified as a person with significant control
10 Mar 2026OfficersAppointment of Mr Lawrence Allen Wang as director on 29 Jan 2026
10 Mar 2026OfficersAppointment of Mr Erik Helge Weiner-Trapness as director on 29 Jan 2026
6 Mar 2026CapitalAllotment of shares (GBP 6,332,529.55) on 20 Feb 2026
20 Mar 2026 Persons With Significant Control

Cessation of Sky Gem Acquisition Limited as a person with significant control on 25 Feb 2026

20 Mar 2026 Persons With Significant Control

Skygem International Holdings Ltd notified as a person with significant control

10 Mar 2026 Officers

Appointment of Mr Lawrence Allen Wang as director on 29 Jan 2026

10 Mar 2026 Officers

Appointment of Mr Erik Helge Weiner-Trapness as director on 29 Jan 2026

6 Mar 2026 Capital

Allotment of shares (GBP 6,332,529.55) on 20 Feb 2026

Recent Activity

Latest Activity

Cessation of Sky Gem Acquisition Limited as a person with significant control on 25 Feb 2026

1 months ago on 20 Mar 2026

Skygem International Holdings Ltd notified as a person with significant control

1 months ago on 20 Mar 2026

Appointment of Mr Lawrence Allen Wang as director on 29 Jan 2026

1 months ago on 10 Mar 2026

Appointment of Mr Erik Helge Weiner-Trapness as director on 29 Jan 2026

1 months ago on 10 Mar 2026

Allotment of shares (GBP 6,332,529.55) on 20 Feb 2026

1 months ago on 6 Mar 2026